Filing Details
- Accession Number:
- 0001628280-23-042628
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-12-22 16:03:35
- Reporting Period:
- 2023-12-22
- Accepted Time:
- 2023-12-22 16:03:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1604019 | Sara Bonstein | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-12-22 | 13,199 | $30.00 | 105,241 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- Includes 821 shares acquired through the Company's 2018 Employee Stock Purchase Plan.